טוען...
Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis
INTRODUCTION: Sepsis is a clinical syndrome associated with a severe systemic inflammation induced by infection. Although different anti-microbial drugs have been used as treatments, morbidity and mortality rates remain high. Mesenchymal stem cells (MSCs) derived from the bone marrow have demonstrat...
שמור ב:
| הוצא לאור ב: | Stem Cell Res Ther |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4609164/ https://ncbi.nlm.nih.gov/pubmed/26474552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-015-0192-0 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|